Evidence map›Paper›PMID 19539570›Full record

ReviewInternational immunopharmacology2009

Chromatin remodeling complex in Treg function.

Anant Jani, Tian Chi, Yisong Y Wan

Open access · greenAbstract readReview
In one paragraph

Review in International immunopharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Anant JaniDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Tian Chi
Yisong Y Wan
Yale University · USUniversity of North Carolina at Chapel Hill · US

Funding

Roles for TAK1 in T Cell Development, Function and TumorigenesisR00AI072956 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WAN, YISONG · 2009 to 2010
$498k
Roles for TAK1 in T cell development, function and tumorigenesisK99AI072956 · NIAID · YALE UNIVERSITY · PI WAN, YISONG · 2008 to 2008
$90k
NIAID NIH HHS K99 AI072956NIAID NIH HHS R00 AI072956
6 · The paper itself

Abstract

Regulatory T cells (Treg), formerly known as suppressor T cells, are essential for maintaining self-tolerance as well as immune homeostasis. Lack of Treg or normal function of Treg often leads to lymphoproliferative syndrome and autoimmunity in human and mouse. The chromatin remodeling BAF complex regulates gene expression through the activity of Brg. Genetic ablation of Brg gene in mouse resulted in early embryonic lethality. T cell failed to develop in the thymus when Brg is deleted at DN stage. Using a Brg conditional KO mouse model, we deleted Brg at the DP stage in the thymus. Unexpectedly, T cells developed and matured normally. However, these mice displayed lympho-proliferative syndrome 2-4 months of age with enlarged peripheral lymphoid organs and leukocyte infiltration in non-lymphoid organs. T cells from these mice turned into effector cells producing increased amounts of effector cytokines as early as 4 weeks after birth. Further analysis revealed that the Treg population was specifically affected by Brg deletion. In this mini-review, we will discuss in detail the properties of Tregs controlled by Brg and the potential underlying mechanisms for an unanticipated, specific role of the Brg-containing BAF complex in controlling Treg functions.

Indexed as

Chromatin Assembly and DisassemblyAnimalsDNA HelicasesHumansMiceMice, KnockoutNuclear ProteinsSelf ToleranceT-Lymphocytes, RegulatoryTranscription FactorsDNA HelicasesNuclear ProteinsSmarca2 protein, mouseSmarca4 protein, mouseTranscription Factors

Identifiers

PMID19539570
PMCPMC2701472
OpenAlexW2067445189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.